TTRX
Turn Therapeutics Inc. Common Stock
NASDAQ: TTRX · HEALTHCARE · BIOTECHNOLOGY
$3.69
+3.81% today
Updated 2026-04-30
Market cap
$107.24M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$3 – $10
Volume
0.0M
Turn Therapeutics Inc. Common Stock (TTRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | — |
| Revenue growth (YoY) | — | — | — |
| Cost of revenue | — | — | — |
| Gross profit | — | — | — |
| Gross margin | — | — | — |
| R&D | $7500.00 | $245956.00 | $265570.00 |
| SG&A | $2.30M | $1.55M | $5.59M |
| Operating income | $-2.31M | $-1.80M | $-5.86M |
| Operating margin | — | — | — |
| EBITDA | $-2.26M | $-1.75M | $-5.81M |
| EBITDA margin | — | — | — |
| EBIT | $-2.31M | $-1.80M | $-5.86M |
| Interest expense | — | — | — |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $-2.29M | $-1.77M | $-3.19M |
| Net income growth (YoY) | — | +22.9% | -80.6% |
| Profit margin | — | — | — |